Phan AT. et al.
Effect of lanreotide depot (LAN) on 5-hydroxyindoleacetic acid (5HIAA) and chromogranin A (CgA) in gastroenteropancreatic neuroendocrine (GEP NET) tumors: Correlation with tumor response and progression-free survival (PFS) from the phase III CLARINET study.
Journal of Clinical Oncology 2017;
35 (Suppl. 15) 4095-4095
Download Bibliographical Data